Palladyne AI Corp.
For the period ended Jun 30, 2025. Filed Aug 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 6, 2025
PDYN$3.57+0.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in thousands)
| Six Months Ended June 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net income (loss) | $15,272 | $(12,552) |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Stock-based compensation | 2,290 | 1,529 |
| Depreciation of property and equipment | 437 | 404 |
| Change in fair value of warrant liabilities | (29,351) | 132 |
| Amortization of investment discount | (647) | (56) |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (103) | 55 |
| Unbilled receivable | (318) | (283) |
| Inventories | (5) | 1,065 |
| Prepaid expenses and other current assets | (26) | 438 |
| Operating lease assets & other non-current assets | 684 | 544 |
| Accounts payable | (120) | (844) |
| Accrued liabilities and current operating lease liabilities | (469) | (2,855) |
| Operating lease liabilities | (486) | (610) |
| Net cash used in operating activities | (12,842) | (13,033) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (93) | (205) |
| Purchases of marketable securities | (47,036) | — |
| Maturities of marketable securities | 14,000 | 16,000 |
| Net cash (used in) provided by investing activities | (33,129) | 15,795 |
| Cash flows from financing activities: | ||
| Proceeds from exercise of stock options | 54 | 4 |
| Proceeds from issuance of common stock under ESPP | 76 | — |
| Proceeds from the exercise of warrants | 6,419 | — |
| Shares repurchased for payment of tax withholdings | — | (72) |
| Payment of obligations under capital leases | — | (2) |
| Proceeds from issuance of common stock | 28,432 | — |
| Payment of transaction costs related to issuance of common stock | (50) | — |
| Net cash provided by (used in) financing activities | 34,931 | (70) |
| Net (decrease) increase in cash and cash equivalents | (11,040) | 2,692 |
| Cash and cash equivalents at beginning of period | 31,188 | 23,139 |
| Cash and cash equivalents at end of period | $20,148 | $25,831 |
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.